Charles River Laboratories (CRL) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents
Trade receivables, net
Inventories
Other current assets
Total current assets
Property, plant and equipment, net
Goodwill, net
Other intangibles, net
Deferred tax asset
Other assets
Total assets
Current portion of long-term debt and capital leases
Accounts payable
Accrued compensation
Deferred revenue
Accrued liabilities
Other current liabilities
Total current liabilities
Long-term debt and capital leases
Other long-term liabilities
Total liabilities
Commitments and contingencies
Preferred stock, $0.01 par value; 20,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.01 par value; 120,000,000 shares authorized; 78,357,166 issued and 51,448,460 shares outstanding at June 25, 2011 and 77,531,056 issued and 56,441,081 shares outstanding at December 25, 2010
Capital in excess of par value
Accumulated deficit
Treasury stock, at cost, 26,908,706 shares and 21,089,975 shares at June 25, 2011 and December 25, 2010, respectively
Accumulated other comprehensive income
Total shareowners' equity
Noncontrolling interests
Total equity
Total liabilities and equity

Entities mentioned with CRL

View All Entities